The Quarterback trials: A phase 2 series of sequential studies of induction chemotherapy followed by reduced dose chemoradiation for human papillomavirus positive oropharynx cancer.

Authors

null

Marshall R. Posner

Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Marshall R. Posner , John Botzler , Mai Takahashi , Scott Roof , Eric Michael Genden , Brett Miles , Richard Lorne Bakst , Erin Moshier , Vishal Gupta , Sonam Sharma , Krzystof Misiukiewicz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT01706939; NCT02945631

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6020)

DOI

10.1200/JCO.2023.41.16_suppl.6020

Abstract #

6020

Poster Bd #

12

Abstract Disclosures